Oxford loses bid to prevent Qiagen from selling QFT-Plus TB test before patent infringement trial, but likely to prevail [Seeking Alpha]
Qiagen N.V. Common Shares (QGEN)
Last qiagen n.v. common shares earnings: 2/4 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
corporate.qiagen.com/investor-relations
Company Research
Source: Seeking Alpha
Oxford loses bid to prevent Qiagen from selling QFT-Plus TB test before patent infringement trial, but likely to prevailA Massachusetts district court hasdenied Oxford Immunotec Global PLC's (OXFD) motion to enjoin Qiagen (QGEN-1%) from promoting its QuantiFERON-TB Gold Plus (QFT-Plus) test to new customers because it did not believe Oxford would suffer irreparable harm in the few months before the start of its patent infringement trial against Qiagen, Quest Diagnostics (DGX-0.8%) and LabCorp (LH-0.2%).The court determined that Oxford was likely to prevail in the case and the infringing aspects of QFT-Plus would be permanently enjoined at that time.Now read:Ironwood Pharmaceuticals Struggles With Slump In Sales, Net Losses »
Show less
Read more
Impact Snapshot
Event Time:
QGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QGEN alerts
High impacting Qiagen N.V. Common Shares news events
Weekly update
A roundup of the hottest topics
QGEN
News
- Global Infectious Disease In vitro Diagnostics Analysis Report 2024: An $80+ Billion Market in 2030 - Investment in Education and Training and Leveraging Artificial Intelligence for Advancements [Yahoo! Finance]Yahoo! Finance
- Exploring New Horizons: BCC Research Forecasts $5.2 Billion Global Induced Pluripotent Stem Cells Market by 2028 [Yahoo! Finance]Yahoo! Finance
- Global Protein Expression Market Outlook 2024-2034: North America and APAC Set for Rapid Expansion [Yahoo! Finance]Yahoo! Finance
- QIAGEN N.V. to release results for Q1 2024 and hold webcast [Yahoo! Finance]Yahoo! Finance
- QIAGEN N.V. to release results for Q1 2024 and hold webcastGlobeNewswire
QGEN
Earnings
- 2/6/24 - Miss
QGEN
Sec Filings
- 3/11/24 - Form 20-F
- 3/11/24 - Form IRANNOTICE
- 2/9/24 - Form SC
- QGEN's page on the SEC website